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Impaired Invariant Chain Degradation and Antigen
Presentation and Diminished Collagen-Induced
Arthritis in Cathepsin S Null Mice
oligomers to the endocytic pathway where Ii is proteolyt-
ically removed. After most of Ii is dissociated, the class
II-bound CLIP fragment is replaced with a great diversity
of peptides derived from endogenous and exogenous
proteins. This step in MHC class II maturation is cata-
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cules are exported to the cell surface for recognition byUniversity of Washington School of Medicine
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ing purified enzymes or cathepsin inhibitors (Watts,University of Tennessee
1997). These in vitro studies demonstrated the involve-and Veteran's Administration Medical Center
ment of the cysteine proteinases cathepsins B, L, andMemphis, Tennessee 38104
S and the aspartyl proteinases cathepsins D and E in
the degradation of Ii and a number of defined exogenous
protein antigens (Blum and Cresswell, 1988; Bennett et
Summary al., 1992; Neefjes and Ploegh, 1992; Avva and Cresswell,
1994; Maric et al., 1994; van Noort and Jacobs, 1994,
Cathepsins have been implicated in the degradation Rodriguez and Diment, 1995; Riese et al., 1996). How-
of proteins destined for the MHC class II processing ever, in sharp contrast with many biochemical in vitro
pathway and in the proteolytic removal of invariant experiments, genetic analyses using cathepsin B± and
chain (Ii), a critical regulator of MHC class II function. D±deficient mice revealed that these two major lyso-
Mice lacking the lysosomal cysteine proteinase ca- somal proteinases are not necessary for Ii degradation
thepsin S (catS) demonstrated a profound inhibition and processing of a number of exogenous and endoge-
of Ii degradation in professional APC in vivo. A marked nous protein antigens (Villadangos et al., 1997; Deussing
variation in the generation of MHC class II-bound Ii et al., 1998; T. N. et al., unpublished data). This sug-
fragments and presentation of exogenous proteins gested that the complexity and redundancy of lyso-
was observed between B cells, dendritic cells, and somal proteinases may impede the elucidation of the
macrophages lacking catS. CatS-deficient mice showed function of individual enzymes. However, our recent
diminished susceptibility to collagen-induced arthritis, analysis of cathepsin L (catL)±deficient mice revealed
suggesting a potential therapeutic target for regula- a profound defect in Ii degradation in thymic cortical
tion of immune responsiveness. epithelial cells (cTEC) but not in bone marrow±derived
APCs (B cells, DC, and Mph). This tissue-specific defect
correlates with the restricted pattern of expression ofIntroduction
cathepsins L and S in these cell typesÐcatL is ex-
pressed in thymic cortical epithelial cells but not in DCMHC class II molecules sample proteolytic fragments
or B cells, whereas catS exhibits the opposite expres-of self and foreign protein antigens generated during
sion pattern (Nakagawa et al., 1998). A role for catS inprotein turnover in endosomes and lysosomes of ªpro-
Ii degradation was supported by biochemical experi-fessionalº antigen-presenting cells (APC), i.e., dendritic
ments utilizing recombinant human catS and a selectivecells (DC), B cells, macrophages (Mph), and certain
catS inhibitor, LHVS, for treatment of APCs in vivo andtypes of specialized epithelium such as thymic epithelial
in vitro (Riese et al., 1996, 1998; Villadangos et al., 1997).cells. Class II heterodimers assemble in the endoplasmic
However, this inhibitor may also act on lysosomal cyste-reticulum with the assistance of invariant chain (Ii), an
ine proteinases other than catS depending upon theabundant type II transmembrane glycoprotein that binds
dosage (Palmer et al., 1995).to and promotes the proper folding of the ab heterodi-
To clarify the specific role of catS in MHC class IImers. A region of Ii encompassing amino acid residues
processing and presentation in vivo, we generated catS-81±104, termed CLIP, associates with the MHC class II
deficient mice by homologous recombination methodol-peptide binding groove and prevents peptide binding
ogy. We analyzed Ii degradation, MHC class II matura-until its removal in later stages of the class II presenta-
tion and presentation of a number of foreign and selftion pathway. Endosomal localization signal sequences
protein antigens by different types of APC (splenic DC,in the cytoplasmic tail of Ii promote targeting of Iiab
B cells, and peritoneal Mph) from catS-deficient mice.
We found that catS is involved in late stages of Ii degra-
dation in ex vivo±isolated DC, B cells, and Mph. The‖ To whom correspondence should be addressed (e-mail: eileen_a_
functional outcome of catS deficiency was dependentelliott@groton.pfizer.com [E. A. E.], sasha@nucleus.immunol.washing
ton.edu [A. Y. R.]). upon the particular APC type, MHC class II allele, and
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antigenic protein analyzed. CatS mutant mice mounted 1992; Loss and Sant, 1993; Maric et al., 1994). To test
whether catS deficiency affects surface expression ofnormal CD41 T cell responses to several foreign protein
antigens but exhibited significantly diminished suscepti- MHC class II molecules, splenocytes from catS2/2 and
littermate control H-2bxq animals were stained with MAbsbility to an experimentally elicited autoimmunity, colla-
gen-induced arthritis (CIA). This finding suggests that AF6 and KH116, specific for I-Ab and I-Aq molecules,
respectively, and analyzed by flow cytometry (FigurecatS may be an attractive candidate for rational drug
design to manipulate the peptide repertoire without ad- 1C). We also stained catS2/2 and wild-type H-2b and
H-2q splenocytes with a panel of 10 MAbs against differ-verse effects on overall class II function.
ent MHC class II epitopes (data not shown). In contrast
to chloroquine- or leupeptin-treated cell lines, overall
Results levels of both MHC class II alleles were not significantly
affected by the loss of cathepsin S function.
Generation and Characterization of Cathepsin Comparable surface expression may not reflect po-
S±Deficient Mice tential differences in the maturation of peptide:class II
Germline transmitting mice deficient in catS expression molecules expressed in mutant versus wild-type spleno-
were generated using gene targeting and embryonic cytes. Since MHC class II dimers bound to high-affinity
stem cell technology. The targeting strategy is shown peptides are stable in 1%±2% SDS at room temperature
in Figure 1A. DBA/1LacJ-252 embryonic stem cells were (Germain and Hendrix, 1991), we assessed generation
electroporated with a gene targeting construct, pJNS2- of SDS-stable I-Ab and I-Aq complexes in mutant and
catS (Figure 1A) (Roach et al., 1995; Griffiths et al., 1997). wild-type splenocytes pulse chase labeled with 35S-
A number of clones incorporated the targeting vector by methionine/cysteine. Cell pellets collected after 0 and
homologous recombination. C57BL/6 (B6) blastocysts 6 hr of chase were lysed and the corresponding MHC
were microinjected with the targeted ES cells, and sub- class II molecules were immunoprecipitated using AF6
sequent offspring were genotyped by Southern analysis and KH116 MAbs. Immunoprecipitates were not boiled
(Figure 1B). CatS homozygous knockout mice were via- prior to loading in 12% SDS polyacrylamide gels to main-
ble and displayed no gross abnormalities. To assess tain intact class II dimers. SDS stable ab I-Ab dimers
the effect of the catS mutation on the function of two (z55 kDa) were readily detected at 6 hr of chase in
different MHC class II alleles, catS2/2 H-2q mice were control immunoprecipitates. In contrast, only minute
bred onto C57Bl/6 (B6) mice to generate catS2/2 H-2qxb amounts of SDS stable ab I-Ab dimers were detected in
mice. Mutant mice as well as their littermate controls catS2/2 splenocytes. Thus, the absence of catS drasti-
were analyzed for the expression of functional catS by cally inhibits generation of mature peptide-loaded I-Ab
cysteine proteinase active-site labeling with 125I-labeled dimers. However, generation of SDS stable ab I-Aq di-
benzyloxycarbonyl-Tyr-Ala-CN2 (Mason et al., 1989). As mers was comparable at 6 hr of chase in mutant and
shown in Figure 1B, catS activity was absent in spleno- wild-type splenocytes (Figure 1D). Sharply decreased
cytes and LPS B cell blasts from catS-deficient mice generation of SDS stable, peptide-bound I-Ab but not
but was readily detectable in cells from littermate control I-Aq dimers in the absence of cathepsin S may reflect
mice. stable association of Ii degradation intermediates (p12±
Lymphoid development in mutant mice was normal 14 SLIP) with I-Ab but not with I-Aq.
as assessed by three-color flow cytometric analysis of Allele-specific differences in appearance of Ii frag-
T and B cell compartments. No significant differences ments were observed in splenocytes from mutant and
in T and B cell development were observed in catS wt mice after pulse chase labeling and In-1 immunopre-
mutant mice on the various backgrounds (H-2q, H-2b, cipitation (Figure 1E). In wild-type H-2b splenocytes,
and H-2qxb) (data not shown). modest amounts of Ii fragments were detected. The
Recent experiments utilizing the selective catS inhibi- largest amounts of 21±22 kDa LIP and 12±14 kDa SLIP
tor LHVS suggested a role for this cysteine proteinase were present immediately after a 40 min pulse and at 1
in degradation of Ii (Riese at al., 1996, 1998; Villadangos hr of chase, repectively, and were found in decreasing
et al., 1997). However, this biochemical approach does amounts at 3 and 6 hr of chase due to their proteolytic
not exclude potential inhibitory effects of LHVS on en- removal (Figure 1E). However, in catS-deficient H-2b
zymes other than catS. To directly test the role of catS splenocytes, LIP fragments were very prominently pres-
in Ii degradation, we performed Western blot analysis ent at 1 hr of chase and subsequently decreased, while
and biosynthetic pulse chase labeling of splenocytes SLIP fragments progressively increased at 3 and 6 hr.
from catS2/2 and control H-2qxb mice using the In-1 MAb, In contrast, comparable kinetics of Ii degradation was
specific for the N-terminal region of murine Ii (Koch et observed in wild-type and mutant H-2q splenocytes with
al., 1982). These experiments revealed accumulation of Ii fragments detected at lower amounts and the effect
Ii degradation intermediates of z21±22 kDa (LIP, leu- of catS deficiency very mild (Figure 1E). These results
peptin induced protein) and z12±14 kDa (SLIP, small clearly identify a set of SLIP Ii fragments as physiological
leupeptin induced protein) in catS-deficient splenocytes catS substrates. Temporal accumulation of LIP (and z17
(data not shown). kDa Ii fragments) in mutant splenocytes suggests that
Acute inhibition of Ii degradation in the presence of these fragments are also normally degraded by catS,
leupeptin or chloroquine in vitro results in intracellular yielding SLIP. However, in the absence of catS, LIP
accumulation of MHC class II molecules bound to LIP can be processed by another unidentified proteinase,
and SLIP, as well as decreased surface class II expres- although with much slower kinetics. The observed MHC
allele-dependent pattern of Ii fragmentation probablysion (Blum and Cresswell, 1988; Neefjes and Ploegh,
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Figure 1. Generation and Characterization of CatS2/2 Mice: Surface MHC Class II Expression, Formation of SDS-Stable Complexes, and Ii
Processing
(A) Homologous recombination of the murine catS gene was performed in DBA1±252 embryonic stem cells. Shown is a diagram depicting
the catS targeting vector (top), endogenous locus (middle), and the targeted cathepsin S locus (bottom). Restriction enzyme sites used in
mapping and Southern analysis were Kp, KpnI; Bg, BglII; B, BamHI; S, SacI; Sp, SpeI; and E, EcoRV. PGK-Neo replaces 3 kb of genomic
locus including the active site cysteine for catS. The outside probe 1 was used to identify targeted ES cell clones. Probe 2, an internal probe,
was used for genotyping subsequent mutant catS mice.
(B) Southern blot of catS1/1, catS1/2, and catS2/2 mice. Genomic DNA isolated from tail cuts of catS offspring was digested with SpeI and
BamHI and hybridized with the internal SacI/BglII 1.5 kb probe 2. The insertion of the neomycin gene into the catS locus creates a shift in
size of the endogenous 5 kb BamHI/SpeI fragment to a 4 kb fragment in the targeted locus. Active site labeling of splenocytes and LPS
induced B cell blasts from catS1/1 and catS2/2 mice. Cells were incubated with the irreversible cysteine proteinase inhibitor Cbz-[125I]-Tyr-
Ala-CN2, and lysed and radiolabeled enzymes were analyzed on a 12% SDS-PAGE gel. Arrows indicate positions of cathepsins B (CB) and
S (CS) in the gel.
(C) Surface expression of MHC class II molecules in mutant mice. Single cell suspensions derived from wild-type and mutant spleen were
stained with biotinylated anti-class II antibodies, Y17 (control/I-Eb/k), AF6 (I-Ab), and KH116 (I-Aq), followed by streptavidin Tricolor, and analyzed
by flow cytometry.
(D) Generation of SDS stable ab dimers in catS2/2 mice. Wild-type and mutant splenocytes were labeled and chased for 0 and 6 hr. I-Ab and
I-Aq molecules were immunoprecipitated with MAbs AF6 and KH116, respectively, and SDS-stable ab dimers were analyzed by running
samples on 12% SDS-PAGE under mildly denaturing conditions (nonboiled, reduced). Arrows indicate positions of SDS stable dimers denoted
by ab, monomeric a, b, and Ii, and m.w. markers.
(E) Ii degradation in splenocytes from H-2b and H-2q mice. Wild-type and mutant H-2b and H-2q splenocytes were pulse labeled and chased
for 0, 1, 3, and 6 hr. Intact Ii and Ii fragments were immunoprecipitated from cell lysates with MAb In-1 and analyzed by 12% SDS-PAGE
under denaturing conditions. Arrows indicate positions of m.w. markers, Ii isoforms, and Ii fragments.
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reflects the different stability of Ii fragments bound to 21 kDa (LIP) and z16±17 kDa fragments at 3 hr of chase
may indicate significantly delayed degradation of 22 kDadifferent MHC class II alleles. Indeed, under nonboiling/
LIP, and 18 and 14 kDa SLIP fragments in DC in thenonreducing conditions, some I-Ab molecules from
absence of catS. Clear differences in the m.w. of minormutant splenocytes migrate as partially SDS-stable
Ii fragments and the kinetics of their accumulation inab:SLIP (z70 kDa) complexes (data not shown) pre-
DC versus B cells suggest that Ii processing in theseviously reported in cells treated with LHVS (Brachet et
cells occurs in endocytic compartments that containal., 1997; Villadangos et al., 1997).
different proteinase activities. As in total splenocytes,
SDS stable I-Ab dimers were not detected at significant
Ii Degradation in Cathepsin S±Deficient Splenic levels over the 6 hr chase period in either B cells or DC
Dendritic Cells and B Cells (data not shown).
For class II I-Aq, SDS-stable dimers were efficientlyThe majority of MHC class II±positive cells in the spleen
generated in catS2/2 splenocytes (Figure 1C), and Ii frag-are B cells, but small numbers of DC expressing very
ments were not detected in significant amounts in I-Aqhigh amounts of class II are present. Therefore, analysis
precipitates from either B cells or DC. Small amountsof bulk splenocytes does not take into account potential
of p14 SLIP were detectable at 6 hr of chase in B cellscell type-specific differences in proteolytic mechanisms
and DC (Figure 2A). This result suggests that Ii fragmentsof MHC class II processing. We had previously reported
dissociate efficiently from I-Aq but not from I-Ab. Simi-cell type-specific expression of two enzymes involved
larly, in LHVS-treated splenocytes, Ii fragments werein Ii degradation in vivo, catL and catS (Nakagawa et
found in association with I-Ab and I-Ad but not I-Ak oral., 1998). We found that catS was active in B cells and
I-Au (Villadangos et al., 1997). This dissociation may beDC while cTECs expressed catL.
catalyzed by DM since in addition to CLIP, larger Ii pro-To test the role of catS in Ii processing in B cells
cessing intermediates, SLIPs, can serve as DM sub-and DC, we analyzed the kinetics of Ii degradation and
strates (Denzin et al., 1996; Stebbins et al., 1996). Theaccumulation of Ii fragments bound to I-Ab and I-Aq in
observed differences may be due either to the low affin-purified splenic B cell and DC populations from mutant
ity of the CLIP region for I-Aq relative to I-Ab or perhapsand wild-type mice. To obtain large numbers of splenic
to MHC class II allele-specific differences in the pH opti-DC, catS-deficient and littermate control mice were
mum of DM-mediated dissociation of Ii fragments. Intreated for 9 days with recombinant flt3 ligand (flt3L).
this regard, DM has a narrow pH optimum for CLIPThis regimen leads to a dramatic expansion of DC pre-
release from I-Ab while DM releases CLIP from I-Ad overcursors and accumulation of large numbers of function-
a broad pH range (L. Denzin, personal communication).ally mature DC in the spleen and lymph nodes of treated
We favor the latter possibility, since our preliminary ex-animals, while T and B cells remain unaffected (Mara-
periments demonstrated efficient binding of CLIP to I-Aqskovsky et al., 1996). Splenic DC and B cells were stained
(data not shown).with anti-B220 and anti-CD11c antibodies. Highly puri-
Since the block in Ii degradation results in a dramaticfied (. 95%) populations of DC (CD11chi, B220lo) and B
accumulation of SLIP fragments while cell surface I-Abcells (CD11clo, B220hi) were isolated by FACS sorting.
was not significantly decreased, the expression of cell
The size of splenic B cell and DC compartments was
surface SLIP: I-Ab complexes on mutant and wild-type
not affected by the catS mutation (data not shown).
DC and B cells was assessed. Flow cytometry experi-
To assess the kinetics of Ii degradation, sorted DC ments were carried out using a novel high-affinity CLIP:I-
and B cells from spleens of flt3L-treated catS2/2 and Ab-specific MAb, 15G4, which also efficiently detects
littermate control mice were pulse labeled for 40 min SLIP but not LIP or intact Ii bound to I-Ab (Liljedahl et
and chased for 0, 1, 3, and 6 hr followed by immunopre- al., 1998; P. Wong and A. Y. R., unpublished data). flt3L-
cipitation with I-Ab- or I-Aq-specific MAb (Figure 2A). induced splenocytes were stained for B220, CD11c, and
Immunoprecipitates were analyzed by SDS-PAGE in either 15G4, AF6 (I-Ab), or KH116 (I-Aq) MAbs. CatS-
7.5%±20% gradient gels in order to allow better separa- deficient (CD11clo, B220hi) B cells expressed reduced
tion of low m.w. Ii fragments. As shown in Figure 2A, surface levels of class II-bound Ii fragments while total
z14 kDa SLIPs were readily detected in association with I-Ab and I-Aq levels were only slightly reduced or unaf-
I-Ab molecules in mutant B cells first after 1 hr of chase fected (Figure 2B). In contrast, 15G4 staining was
and in increasing amounts thereafter. Smaller 12 and sharply augmented on catS-deficient (CD11chi, B220lo)
13 kDa SLIPs were observed at 3 and 6 hr of chase, DC compared to wt DC (Figure 2B). To demonstrate
which most likely reflect a slow rate of degradation of SLIP surface expression biochemically, cell surface pro-
14 kDa SLIPs by a lysosomal proteinase other than catS. teins on B cells and DC from mutant and wild-type H-2b
Low levels of 21 and 17 kDa Ii fragments were observed mice were biotinylated and precipitated on strepavidin-
in mutant B cells continuously throughout the chase agarose. Western blot analysis of precipitates with In-1
period suggesting that these fragments are also de- MAb revealed p12±14 kDa SLIP fragments expressed
graded by catS. In contrast, Ii fragments were undetect- on the surface of both B cells and DC (Figure 2C).
able in I-Ab precipitates from control B cells, with the The disparity in 15G4 staining between mutant B cells
exception of a weak 14 kDa SLIP signal at 1 hr of chase and DC correlates with the distinct kinetics and pattern
(Figure 2A). of Ii degradation observed in these cell types (Figure
Similar analysis of catS2/2 DC showed abundant 2A). This result may reflect localization of Ii degradation
amounts of I-Ab-bound Ii fragments of z14, 18, and 22 to distinct endocytic compartments that are quantita-
kDa at 1 hr of chase. The appearance of additional 13 tively and/or qualitatively different in proteinase and DM
activity.kDa bands similar to those in mutant B cells as well as
Role of Cathepsin S in MHC Class II Presentation
211
Figure 2. Invariant Chain Degradation in CatS-Deficient B Cells and DC
(A) Splenic B cell and DC populations from flt3L-treated wild-type and mutant mice were stained with anti-B220-PE and anti-CD11c-FITC
antibodies and then isolated by sorting on a Mo-Flo high speed sorter. Highly purified populations of B cells and DC were pulse-labeled and
chased for 0, 1, 3, and 6 hr. Cell lysates were immunoprecipitated with the I-Ab specific MAb AF6 or I-Aq-specific MAb KH116 and immunoprecipi-
tates were analyzed by 7.5%±20% gradient SDS-PAGE under denaturing conditions.
(B) Differential expression of Ii fragments bound to I-Ab complexes on catS-deficient B cells and DC. Flt3L-induced splenocytes were stained
with anti-B220-PE, anti-CD11c-FITC, and biotinylated class II-specific MAbs followed by streptavidin-Tricolor. B cells (CD11clo, B220hi) and
DC (CD11chi, B220lo) were analyzed for expression of I-Ab, I-Aq, and CLIP/SLIP:I-Ab complexes. Results are representative of three independent
experiments. Cathepsin S, CS.
(C) Cell surface expression of SLIP fragments on catS2/2 B cells and DC. Highly purified populations of wild-type (1/1) and mutant (2/2) B
cells and DC were biotinylated on ice and lysates were precipitated on streptavidin-agarose. Western blot analysis of total (T) and streptavidin-
bound surface (S) proteins with the In-1 MAb revealed p12±14 kDa SLIP fragments expressed on the surface of both B cells and DC. The
right panel denoted by ** shows a longer exposure of the same B cell blot.
Ii Degradation and MHC Class II Maturation maturation in catS2/2 IFNg induced peritoneal macro-
phages revealed I-Ab-bound z14 kDa SLIP fragmentsin Cathepsin S±Deficient Macrophages
Unlike B cells and DC, activated wild-type Mph express at 1, 3, and 6 hr of chase (Figure 3A). After peaking at
3 hr, the amount of SLIP decreased at 6 hr of chase,both catS and catL. We did not observe any compensa-
tory increase in catL activity in catS2/2 Mph (data not and the additional Ii fragments observed in DC and B
cells were not detectable in Mph. This contrasts with theshown). Therefore, it was of particular interest to exam-
ine MHC class II processing and Ii degradation in Mph increasing accumulation of SLIP fragments observed in
B cells and DC (Figure 2A). Furthermore, analysis ofto assess any redundancy of function between catS and
catL. SDS-stable I-Ab dimers showed comparable generation
of peptide: I-Ab complexes in catS2/2 Mph (Figure 3A).Pulse chase analysis of Ii degradation and class II
Immunity
212
of catS-deficient B cells, DC, and macrophages to pre-
sent endogenous peptides derived from IgM, b2-micro-
globulin, CD22, b-actin, and rab5 to these T cells (Figure
4). We found that presentation of the major endoge-
nous peptides by I-Ab is not significantly affected by
catS deficiency although presentation of b2m peptide
by catS2/2 B cells and rab5 peptide by catS2/2 DC is
somewhat decreased. Interestingly, presentation of the
IgM as well as rab5 peptides by catS-deficient macro-
phages was somewhat enhanced, which may indicate
an inhibitory role of catS in the generation of these epi-
topes. Modest enhancement of presentation of some
exogenous protein antigens has likewise been observed
in cathepsin D± and B±deficient APCs (Deussing et al.,
1998; T. Y. N. and A. Y. R, unpublished data).
We next assessed the effects of catS deficiency on
the ability of purified splenic B cells, DC, and peritoneal
Mph to present a panel of exogenous protein antigens
to I-Ab- and I-Aq-restricted T cell hybridomas. As evident
from Figure 5A, the ability of catS-deficient B cells to
present the soluble protein antigens myoglobin, KLH,
T. cruzi SA85 protein, and HEL to I-Ab-restricted T cell
hybrids of corresponding specificities was completely
blocked or sharply reduced. CatS2/2 DC also showed
significantly suppressed presentation of all exogenous
antigens by I-Ab when compared to wild-type DC. How-
ever, the degree of inhibition varied, depending on the
antigen (Figure 5A). Heat-inactivated C. trachomatis wasFigure 3. Ii Degradation, MHC Class II Maturation, and Surface Ex-
pression in CatS-Deficient Macrophages not presented by resting wild-type and catS2/2 B cells
(data not shown) or catS2/2 DC, but wild-type DC were(A) IFNg-activated peritoneal macrophages were pulse labeled and
chased for 0, 1, 3, and 6 hr. I-Ab complexes were immunoprecipitated able to present this antigen to T cells (Figure 5A).
and immunoprecipitates were analyzed on 7.5%±20% gradient SDS- In contrast to B cells and DC, presentation of some
PAGE with boiling (B) or without boiling (NB). exogenous protein antigens by mutant Mph was unaf-
(B) Mph were stained with anti-CD11b-PE, anti-F4/80-FITC, and fected (KLH, myoglobin) whereas presentation of others
biotinylated class II-specific MAbs, followed by streptavidin-Tricolor
was significantly inhibited (T. cruzi SA85, C. trachomatis)and analyzed by flow cytometry. I-Ab, I-Aq, and CLIP:I-Ab expression
(Figure 5A). In catS2/2 Mph, the Ii degradation defect isis shown for the electronically gated F4/801 CD11b1 cell population.
at least partially compensated for by catL, suggestingCathepsin S, CS.
that catS may be selectively involved in the generation of
the stimulatory T. cruzi SA85 and C. trachomatis peptide
epitopes. Alternatively, presentation of these proteinsIn agreement with this result, the surface levels of I-Ab
may be more sensitive to a slower rate or altered com-and CLIP/SLIP:I-Ab complexes as well as I-Aq in catS2/2
partmentalization of Ii degradation in catS-negative Mph.and control Mph were comparable (Figure 3B). The bi-
In parallel experiments, the same APC populationsmodal distribution of I-Aq and not I-Ab in catS2/2 Mph is
were used in analogous assays for I-Aq restricted pre-
consistent with a recent report describing differential
sentation of three exogenous antigens: bovine type II
turnover of these two MHC class II alleles on activated
collagen (II), HEL, and ovalbumin. As expected from the
macrophages but not B cells (Baumgart et al., 1998). largely unaffected maturation of I-Aq molecules (Figure
Since Mph express both catS and catL, our results sug- 1D), catS-deficient B cells, DC, and Mph presented HEL
gest that in the absence of catS, catL is still able to and OVA to corresponding T cell hybrids equally well
mediate late stages of Ii degradation but with somewhat or even more efficiently than did APCs isolated from
slower kinetics. littermate control mice (Figure 5B). Therefore, it was
surprising to find a block in the presentation of the colla-
Presentation of Endogenous and Exogenous gen type II epitope, 260±270, by catS-deficient Mph and
Antigens by Cathepsin S±Deficient APCs DC to the qCII85.33 T cell hybridoma (Rosloniec et al.,
Since the majority of peptides bound to class II are 1996) of the corresponding specificity (Figure 5B). It
derived from self proteins, we focused on the effect of should be noted that B cells from both mutant and con-
the catS null mutation on the presentation of peptides trol mice were unable to present this exogenous protein
derived from major endogenous proteins. Recently, we (Figure 5B). Thus, this particular epitope is efficiently
have sequenced a large number of self peptides bound presented by Mph and DC but not polyclonal B cells.
to I-Ab molecules in B cells and macrophages and gener- Overall, inefficient presentation of exogenous protein
ated a panel of T cell hybrids specific for some of these antigens by catS-deficient APC populations can be as-
endogenous complexes (Grubin et al., 1997; Kovats et cribed to Ii and antigen processing defects, since exoge-
nously provided antigenic peptides were presentedal., 1998; Dongre et al., submitted). We tested the ability
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Figure 4. Presentation of Endogenous Pro-
tein Antigens by CatS-Deficient APC
Graded numbers of purified B cells, DC, and
macrophages from wild-type and mutant
mice were incubated with the following T hy-
brids specific for endogenous antigens: IgM
(77.1), actin (15.10), b2m (4.1), CD22 (7.6), and
rab5 (33.7). IL-2 production was assessed us-
ing HT-2 proliferation as determined by Ala-
mar Blue colorimetric assay. The results are
expressed as arbitrary OD units (A570-A600).
Standard deviations in all experiments were
less than 10% of the mean. Results are shown
for one out of three identical experiments.
Cathepsin S, CS.
comparably by mutant and wild-type APC (data not immunized at the base of the tail on day 0 and 21 with
type II chick collagen in complete Freund's adjuvantshown).
(CFA). Disease severity was scored starting on day 28
according to previously published protocols (Griffiths etInduction of Collagen-Induced Arthritis
in Cathepsin S±Deficient Mice al., 1995). These experiments revealed significant resis-
tance of catS null mice to CIA induction with greatlyTo test whether impaired Ii degradation and antigen
presentation in catS-deficient mice affects their suscep- reduced severity of the disease at all time points in
mutant versus wild-type mice (Figure 6A). In one of thesetibility to experimentally elicited autoimmunity, we as-
sessed development of CIA in mutant and wild-type experiments, none of the mutant mice were affected by
the disease (mean severity score 0.0 6 0.1), while theH-2q DBA1/LacJ mice. Mutant and wild-type mice were
Figure 5. Presentation of Exogenous Protein
Antigens by CatS-Deficient APCs
Purified populations of catS2/2 and catS1/1
B cells, DC, and peritoneal Mph were used to
stimulate (A) I-Ab-restricted T hybrids specific
for HEL (BO4), KLH (2BH11. A1), myoglobin
(4.2.2), T. cruzi SA85 (71.5), and C. tracho-
matis (116.3), or (B) I-Aq-restricted T cell hy-
brids specific for HEL (qLy30.0), OVA (qO/
H166.0) and bovine collagen type II (qCII85.33).
B cells (1.0 3 105/well), DC (0.2 3 105/well),
and Mph (0.5 3 105/well) were incubated with
1 3 105 T hybrids with titrated amounts of
exogenous antigens. IL-2 production was as-
sessed using HT-2 proliferation as deter-
mined by the Alamar Blue colorimetric assay.
The results are expressed as arbitrary OD
units (A570-A600). Standard deviations in all ex-
periments were less than 10% of the mean.
Results are shown for one out of three identi-
cal experiments. Cathepsin S, CS.
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Figure 7. Distinct Patterns of Invariant Chain Degradation in B Cells,
Macrophages, Dendritic Cells, and Cortical Thymic Epithelial Cells
The lumenal region of Ii (p31/p41) is first cleaved by one or more
unknown non-cysteine proteinases (Maric et al., 1994; Villadangos
et al., 1997), generating 21±22 kDa LIP (p21±22) fragments. Degrada-
tion of LIP (p21±22) fragments leading to the generation of SLIP
(p12±14) fragments is performed by either catL (CL), catS (CS), an
unknown cysteine proteinase, or any combination of the three. Major
fragments are shown in larger bold type and unknown cathepsins
are designated by question mark. Related LIP and SLIP fragments
are shown in brackets. Minor p17 and p18 Ii fragments observed in
B cells and DC are not incorporated into the diagram.
Discussion
Experiments utilizing various cysteine proteinase inhibi-
tors for treatment of Mph or B cell lines or murine spleno-
cytes in vitro revealed that Ii degradation proceeds in a
stepwise fashion. These experiments suggested that a
non-cysteine proteinase(s), possibly an aspartyl protein-
Figure 6. Diminished Susceptibility to Collagen-Induced Arthritis
ase, is responsible for early stages of Ii degradationand Decreased Collagen-Specific Antibodies in CatS-Deficient Mice
while a cysteine proteinase(s) is acting at a later step(A) CIA induction in catS2/2 mice. Mutant and wild-type mice were
(Blum and Cresswell, 1988; Maric et al., 1994, Villa-immunized at the base of the tail on day 0 and 21 with type II chick
dangos et al., 1997). We have recently found that cathep-collagen in CFA. Disease severity was scored on days 28, 31, and
34. Results shown are representative of three similar experiments. sin L mediates the late stages of Ii degradation in vivo
Cathepsin S, CS. in a tissue-specific fashion. Inactivation of catL leads
(B) Reduced levels of anti-collagen antibodies in immunized catS2/2 to accumulation of p21±22 LIP and p12±14 SLIP frag-
mice. Collagen-specific antibodies of different isotypes were mea-
ments in cTEC but not in bone marow±derived APCsured in the titrated sera of mice (WT and catS2/2 immunized, WT
(Nakagawa et al., 1998). This suggested that catS, likenonimmunized) at the termination of the experiment (day 58) by
catL, may play an important role in late stages of IiELISA. OD450 values within the linear range of the titration curve are
shown. Results are the average of two identical experiments. degradation in vivo but only for bone marrow±derived
professional APC.
Experiments performed with catS-deficient profes-control group developed disease (mean severity score
sional APCs indicate that catS is critically involved in2.4 6 1.3). The difference in CIA development in mutant
the late stages of Ii degradation. CatS-deficient B cellsversus wt mice correlated with the diminished levels of
and DC accumulate Ii processing intermediates and de-anti-collagen antibodies, particularly of the IgG1 and
fectively present numerous exogenous protein antigens.IgG2b isotypes, in the serum of mutant mice 58 days
While presentation of a majority of exogenous proteinafter priming (Figure 6B).
antigens by I-Ab was inhibited by catS deficiency, theImportantly, catS deficiency did not result in general
presentation of several major endogenous self antigensunresponsiveness of CD41 T cells to foreign protein
was not significantly affected. However, the markedlyantigens. Mutant and wild-type H-2b and H-2q mice im-
delayed kinetics of I-Ab SDS-stable dimer formation sug-munized with ovalbumin or HEL in CFA showed normal in
gests that generation of at least some endogenous pep-vitro T cell proliferative responses when draining lymph
tide:class II complexes must be reduced in mutantnodes were isolated on day 9 after priming (data not
APCs. In Mph, catL can partially compensate for the lackshown). This may be due to efficient Mph-mediated pre-
of catS so that Ii degradation and antigen processing aresentation of these antigens in vivo or epitope selection
not severely impaired in catS-negative Mph relative toin catS2/2 DC or B cells. These results suggest that catS
B cells and DC. The moderate Ii processing defect inholds promise as a potential target for rational drug
catS2/2 Mph may result from a lower activity of catLdesign to selectively affect the development of certain
versus catS due to specific downmodulation of its activ-adverse autoimmune responses without detrimental ef-
fects on overall class II function. ity by the p41 isoform of Ii (Bevec et al., 1996; Fineschi
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et al., 1996). Further analysis of catL and catS double endocytic compartment positioned between early and
late endosomes where Ii degradation is initiated (Kleij-deficient Mph will conclusively address the compensa-
tory role of these enzymes. meer et al., 1997; Morkowski et al., 1997).
Analysis of antigen presentation by catS null APCDetailed analysis of Ii degradation in B cells, DC, and
Mph from catS2/2 and wild-type mice and our previous showed that the inhibitory effect of catS deficiency on
MHC class II function can be selective as demonstratedfindings in catL-deficient mice suggest a model of Ii
processing by lysosomal enzymes in the four main types by the reduced presentation of collagen (II) by catS2/2
DC and Mph. The sequence of the 260±270 region isof MHC class II-positive cells as shown in Figure 7.
These experiments revealed cell-type specific differ- highly conserved between different species and repre-
sents the major collagen (II) T cell epitope presented byences in the pattern of Ii degradation, suggesting quanti-
tative and qualitative differences in the proteolysis in- DBA/1 mice. This epitope has been found to play a
central role in promoting autoantibody production andvolved in MHC class II processing. The block in Ii
degradation in B cells and DC also resulted in strikingly induction of collagen-induced arthritis in this model
(Brand et al., 1994). Thus, catS is selectively involved,different effects on the surface expression of class II
molecules bound to Ii fragments as revealed by 15G4 either directly or indirectly, in processing of this model
autoantigen. This finding is of interest for evaluation ofMAb staining: a significant decrease in B cells and a
sharp increase in DC. Interestingly, we also observed the role of specific cathepsins in generation of autoanti-
gens in vivo. Results from the in vivo collagen-inducedan increased expression of surface Ii fragments bound
to class II on catL-deficient cTEC (Nakagawa et al., 1998) arthritis model indicate that the absence of catS dimin-
ishes the onset and severity of disease in DBA/1 mice.suggesting similarities in regulation of class II export
It is not clear from the current data if the altered responsebetween cTEC and DC.
is a result of a change in the in vivo kinetics of antigenThese differences may explain the distinct pattern of
presentation or a result of a decrease in the level ofpresentation of exogenous protein antigens exhibited
collagen peptide antigens presented. Alternatively, theby normal DC, B cells, and Mph. We found differential
lack of disease may reflect a change in the repertoirepresentation of collagen (II) by Mph and DC but not
of antigenic peptides presented and the specificity ofpolyclonal B cells. Previously, differences in MHC class
the anti-collagen antibody produced. Further studiesII processing and presentation between different APC
will evaluate the detailed kinetics of the anti-collagentypes have been reported (Moreno et al., 1991; Guery
antibody response as well as the fine specificity of theet al., 1996; Robadey et al., 1996) but the underlying
resulting antibodies.mechanism(s) responsible for these differences have
In conclusion, we have demonstrated that catS playsnot been defined.
a major role in late stages of Ii degradation and influ-A recent study suggested that activation-dependent
ences the repertoire of peptides presented by MHCcatS mediated degradation of Ii is a critical event for
class II molecules in B cells and DC. The effect of catSMHC class II transport to the cell surface during DC
deficiency on MHC class II processing and presentationmaturation (Pierre and Mellman, 1998). Cystatin C, an
in Mph is subtleÐprobably the result of the overlappingendogenous inhibitor of lysosomal cysteine proteinases
function of catS and catL. This study suggests that(Barrett, 1987; BroÈ mme et al., 1991), is downregulated
blocking of catS may result in the selective inhibition ofupon TNFa induction of immature bone marrow±derived
presentation of low abundance class II-bound peptidesDC, resulting in increased catS activity, efficient pro-
and peptides derived from proteins that specifically re-cessing of Ii, and augmented export of class II to the
quire catS for their processing. Our study of catS-defi-cell surface (Pierre and Mellman, 1998).
cient mice suggests that this cysteine proteinase mayOur observation of comparable surface class II ex-
be used for manipulation of the peptide repertoire dis-pression in both wild-type and mutant nonactivated DC
played by MHC class II molecules and may serve as aimplies that mechanisms of MHC class II export to the
target for selective drug therapy of certain autoimmunecell surface may differ in TNF-a-activated versus nonac-
diseases.tivated DC by their dependency on cystatin C levels.
The apparent contradiction between this observation
Experimental Proceduresand that by Pierre and Mellman (1998) may be explained
by differential compartmentalization of Ii degradation in Gene Targeting of Cathepsin S and Generation
unstimulated versus activated DC. Perhaps in unstimu- of Knockout Mice
lated DC, monomeric cystatin C inhibits catS activity in A 498 bp murine cathepsin S partial cDNA fragment was used as a
probe to identify genomic clones from a murine DBA/1LacJ genomica compartment with a relatively high pH but not in low
phage library (Stratagene, La Jolla, CA). The cathepsin S targetingpH late endocytic compartments where it is present as
vector was created by cloning 3.5 kb of 59 homology and 6.0 kban inactive dimer (Merz et al., 1997). This would explain
of 39 homology in pJNS2 (PGK-Neo/PGK-Tk vector). The targeting
efficient presentation of peptides generated in late en- vector replaces 3.0 kb of genomic locus, containing the active site
dosomal/lysosomal MIIC compartments in these cells. cysteine, with PGK-Neo. Positive/negative selection was used on
Upon cystatin C downregulation, Ii chain may be pro- DBA-252 embryonic stem (ES) cells (Roach et al., 1995; Griffiths et
al., 1997) electroporated with linearized pJNS2-catS targeting vec-cessed in a relatively early compartment with high pH
tor. Targeted ES cells were identified by Southern analysis using anso that MHC class II molecules are exported to the cell
outside 2.0 kb BglII fragment. C57BL/6j blastocysts were microin-surface prior to entering the main peptide loading late
jected with targeted ES cells and transferred to pseudopregnant
compartments. In fact, our recent studies of MHC class CD-1 females. Subsequent catS mutant offspring were genotyped
II containing compartments in B cells suggested that by Southern analysis using an internal 1.5 kb SacI/BglII fragment
as probe.newly synthesized ab:Ii oligomers first arrive at an early
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Flow Cytometric Analyses and Isolation of DC, mM L-glutamine, 10 mM HEPES, antibiotics, and 5% dialyzed FCS
B Cells, and Mph (labeling medium). Cells were pulsed (2±5 3 106 cells/ml) for 40
To assess MHC class II expresssion on splenic B cells, two-color min with 1 mCi/ml 35S-methionine/cysteine (Trans 35S-label, ICN) in
flow cytometric analyses were performed. Wild-type and mutant SC labeling medium and chased for 0, 1, 3, and 6 hr in 303 methionine/
were stained with anti-B220-PE MAb (Pharmingen) and biotinylated cysteine containing RPMI 1640 with supplements. Pulse chase la-
MAbs Y17 (anti-I-Eb/k; ATCC HB197), I-Ab-recognizing MAbs AF6- beled cells were lysed in 1% NP-40, 0.1 M Tris (pH 7.3), supple-
120.1.2 (ATCC HB163), 15G4 (CLIP-I-Ab) (Wong and A. Y. R., unpub- mented with a cocktail of protease inhibitors. I-Ab, I-Aq, and Ii were
lished data), and I-Aq-specific MAb KH116 (Pharmingen). Biotinyl- immunoprecipitated with AF6-120.1.2, KH116, and In-1 MAbs (Koch
ated class II-specific Abs were detected with streptavidin-Tricolor et al., 1982) as described (Rudensky et al., 1994). Immunoprecipi-
(Caltag) and analyzed on a FACScan flow cytometer (Becton-Dick- tates were analyzed by SDS-PAGE in 7.5%±20% gradient gels or
inson). in 12% gels.
To induce DC, catS mutant mice and wild-type littermate controls Cell surface biotinylation was performed by incubation of purified
were subcutaneously injected daily with 10 mg of recombinant hu- cell populations (1 3 108/ml) with 0.5 mg/ml NHS-LC-biotin (Pierce)
man flt3 ligand (Immunex Corporation) for 9 days (Maraskovsky et in PBS for 30 min on ice. The reaction was stopped by three washes
al., 1996; Pulendran et al., 1997). Splenocytes were stained with with ice-cold RPMI-5% FCS and PBS. Cell pellets were lysed and
anti-B220-PE and anti-CD11c-FITC MAbs (both Pharmingen) in ad- biotinylated cell surface proteins were precipitated by strepavidin-
dition to the biotinylated class II specific MAbs (Y17, Y3P, KH116, agarose (Sigma). Precipitates were released by boiling in SDS sam-
15G4), followed by streptavidin-Tricolor. In some experiments, cells ple buffer, separated in 12% SDS-PAGE, and analyzed by Western
were stained with anti-CD11b-PE, CD11c-FITC, and the biotinylated blotting using In-1 MAb.
anti-class II MAbs. The B2202 N4181 DC population was electron- Cysteine proteinase active site labeling: 1-5 3 105 cells were incu-
ically gated and assessed for class II expression. Highly purified bated for 2 hr at 378C with the iodinated cysteine proteinase inhibitor
populations of DC and B cells were isolated by sorting for B220hiCD-
Cbz-[125I]-Tyr-Ala-CN2 (Mason et al., 1989). Cells were washed, lysed,11clo B cells and B220lo CD11chi DC on a Mo-Flo cytometer (Cyto-
and analyzed by 12% SDS-PAGE.
mation).
To induce Mph, mice were injected intraperitoneally with 10%
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